XP (XP)
(Real Time Quote from BATS)
$18.12 USD
+0.09 (0.50%)
Updated Oct 2, 2024 10:40 AM ET
5-Strong Sell of 5 5
C Value B Growth F Momentum C VGM
Income Statements
Fiscal Year end for XP Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,976 | 2,585 | 2,238 | 1,581 | 1,299 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 2,976 | 2,585 | 2,238 | 1,581 | 1,299 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,007 | 1,820 | 1,487 | 1,091 | 887 |
Income After Depreciation & Amortization | 970 | 766 | 751 | 491 | 413 |
Non-Operating Income | -58 | -21 | -19 | -11 | 0 |
Interest Expense | 124 | 78 | 25 | 10 | 21 |
Pretax Income | 788 | 667 | 707 | 470 | 391 |
Income Taxes | 7 | -26 | 41 | 66 | 115 |
Minority Interest | 0 | 0 | 1 | 1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 781 | 693 | 666 | 404 | 276 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 781 | 693 | 665 | 403 | 274 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,020 | 806 | 794 | 518 | 436 |
Depreciation & Amortization (Cash Flow) | 51 | 40 | 43 | 28 | 23 |
Income After Depreciation & Amortization | 970 | 766 | 751 | 491 | 413 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 540.03 | 572.80 | 573.50 | 559.11 | 511.71 |
Diluted EPS Before Non-Recurring Items | 1.45 | 1.21 | 1.16 | 0.72 | 0.50 |
Diluted Net EPS (GAAP) | 1.43 | 1.21 | 1.16 | 0.72 | 0.54 |
Fiscal Year end for XP Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 808.41 | 818.27 | 810.15 | 846.22 | 716.82 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 808.41 | 818.27 | 810.15 | 846.22 | 716.82 |
SG&A, R&D, and Dept/Amort Expenses | 503.92 | 543.78 | 558.84 | 559.90 | 482.54 |
Income After SG&A, R&D, and Dept/Amort Expenses | 304.49 | 274.49 | 251.31 | 286.32 | 234.28 |
Non-Operating Income | -0.35 | -18.12 | -18.63 | -21.58 | -8.02 |
Interest Expense | 39.03 | 36.61 | 33.83 | 27.71 | 30.79 |
Pretax Income | 265.11 | 219.76 | 198.84 | 237.03 | 195.47 |
Income Taxes | 50.91 | 11.89 | -9.14 | 14.50 | -1.85 |
Minority Interest | 0.13 | -0.09 | -0.43 | 0.09 | 0.30 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 214.19 | 207.87 | 207.97 | 222.53 | 197.32 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 214.07 | 207.96 | 208.40 | 222.44 | 197.02 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 550.74 | 556.68 | 547.37 | 554.59 | 528.11 |
Diluted EPS Before Non-Recurring Items | 0.39 | 0.37 | 0.38 | 0.40 | 0.37 |
Diluted Net EPS (GAAP) | 0.39 | 0.37 | 0.38 | 0.40 | 0.37 |